Clinical Trial Update: Veliparib and Temozolomide in Treating Patients With Recurrent Glioblastoma [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update reporting results from a Phase 1/2 study of veliparib plus temozolomide in patients with recurrent glioblastoma; the trial has completed a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma

Drugs mentioned

• Temodar (Temozolomide)
• Veliparib (veliparib)

Snippet

Sponsor: Radiation Therapy Oncology Group | Conditions: Brain and Central Nervous System Tumors | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2017-07-02